Scutellarein inhibits cancer cell metastasis in vitro and attenuates the development of fibrosarcoma in vivo

International Journal of Molecular Medicine

Volumn 35, Issue 1, 2015, Pages 31-38

  Shi, Xiujuan ^a   Chen, Guangfeng ^a   Liu, Xiaoqiang ^a   Qiu, Yu ^a   Yang, Shuzhang ^a   Zhang, Yan ^a   Fang, Xuexun ^b   Zhang, Chen ^a   Liu, Xiaoqing ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

HT1080 cells; Invasion; Matrix metalloproteinase; Metastasis; Scutellarein

Indexed keywords

ANTINEOPLASTIC AGENT; DIMETHYL SULFOXIDE; GELATINASE A; GELATINASE B; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE 14; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SCUTELLAREIN; APIGENIN; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SIZE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROSARCOMA; FIBROSARCOMA CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; CELL MOTION; CELL TRANSFORMATION; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APIGENIN; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FIBROSARCOMA; GENE EXPRESSION; HUMANS; MALE; MATRIX METALLOPROTEINASES; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR BURDEN; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84917708546     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1997     Document Type: Article

References (32)

1. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
2. Joyce JA and Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252, 2009.
3. Psaila B and Lyden D: The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9: 285-293, 2009.
4. Weigelt B, Peterse JL and van't Veer LJ: Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591-602, 2005.
5. Liotta LA: Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. Am J Pathol 117: 339-348, 1984.
6. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002.
7. Nagase H and Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
8. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003.
9. Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006.
10. Mehlen P and Puisieux A: Metastasis: a question of life or death. Nat Rev Cancer 6: 449-458, 2006.
11. Nuti E, Tuccinardi T and Rossello A: Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors. Curr Pharm Des 13: 2087-2100, 2007.
12. Gao R, Zhu BH, Tang SB, Wang JF and Ren J: Scutellarein inhibits hypoxia- and moderately-high glucose-induced proliferation and VEGF expression in human retinal endothelial cells. Acta Pharmacol Sin 29: 707-712, 2008.
13. Li NG, Song SL, Shen MZ, Tang YP, Shi ZH, Tang H, Shi QP, Fu YF and Duan JA: Mannich bases of scutellarein as thrombin-inhibitors: design, synthesis, biological activity and solubility. Bioorgan Med Chem 20: 6919-6923, 2012.
14. Goh D, Lee YH and Ong ES: Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agr Food Chem 53: 8197-8204, 2005.
15. Chen G, Shi X, Sun C, Li M, Zhou Q, Zhang C, Huang J, Qiu Y, Wen X, Zhang Y, et al: VEGF-mediated proliferation of human adipose tissue-derived stem cells. PloS One 8: e73673, 2013.
16. Helbig G, Christopherson KW 2nd, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and Nakshatri H: NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631-21638, 2003.
17. Luo JL, Kamata H and Karin M: IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest 115: 2625-2632, 2005.
18. Harvey AL: Natural products in drug discovery. Drug Discov Today 13: 894-901, 2008.
19. Koehn FE and Carter GT: The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4: 206-220, 2005.
20. Pan ZW, Feng TM, Shan LC, Cai BZ, Chu WF, Niu HL, Lu YJ and Yang BF: Scutellarin-induced endothelium-independent relaxation in rat aorta. Phytother Res 22: 1428-1433, 2008.
21. Chan JY, Tan BK and Lee SC: Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation. Anticancer Res 29: 3043-3047, 2009.
22. Li H, Huang D, Gao Z, Lv Y, Zhang L, Cui H and Zheng J: Scutellarin inhibits cell migration by regulating production of αvβ6 integrin and E-cadherin in human tongue cancer cells. Oncol Rep 24: 1153-1160, 2010.
23. Qian LH, Li NG, Tang YP, Zhang L, Tang H, Wang ZJ, Liu L, Song SL, Guo JM and Ding AW: Synthesis and bio-activity evaluation of scutellarein as a potent agent for the therapy of ischemic cerebrovascular disease. Int J Mol Sci 12: 8208-8216, 2011.
24. Chaffer CL and Weinberg RA: A perspective on cancer cell metastasis. Science 331: 1559-1564, 2011.
25. Muller A, Homey B, Soto H, Ge NF, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
26. Fidler IJ: Timeline - the pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458, 2003.
27. Eccles SA and Welch DR: Metastasis: recent discoveries and novel treatment strategies. Lancet 369: 1742-1757, 2007.
28. Geiger TR and Peeper DS: Metastasis mechanisms. Biochim Biophys Acta 1796: 293-308, 2009.
29. Coussens LM, Fingleton B and Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392, 2002.
30. Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
31. Perkins ND: The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer 12: 121-132, 2012.
32. Orlowski RZ and Baldwin AS: NF-κB as a therapeutic target in cancer. Trends Mol Med 8: 385-389, 2002.